Abbott Labs Files 2024 10-K
Ticker: ABT · Form: 10-K · Filed: 2025-02-21T00:00:00.000Z
Sentiment: neutral
Topics: 10-K, annual-report, healthcare
TL;DR
ABT filed its 2024 10-K. Full financials and biz details inside.
AI Summary
Abbott Laboratories filed its 2024 10-K on February 21, 2025, reporting on its fiscal year ending December 31, 2024. The company, headquartered at 100 Abbott Park Road, Abbott Park, IL 60064-3500, operates in the Pharmaceutical Preparations industry. Key financial details and business segments are outlined within the filing, providing a comprehensive overview of its performance and operations for the year.
Why It Matters
This filing provides investors and analysts with a detailed look at Abbott Laboratories' financial health, operational performance, and strategic direction for the fiscal year 2024.
Risk Assessment
Risk Level: low — A 10-K filing is a standard annual report and does not inherently indicate increased risk.
Key Players & Entities
- ABBOTT LABORATORIES (company) — Filer
- 0000001800 (company) — Central Index Key
- 100 ABBOTT PARK ROAD (company) — Business Address
- ABBOTT PARK (company) — City
- IL (company) — State
- 60064-3500 (company) — ZIP Code
- 2246676100 (company) — Business Phone
FAQ
What was Abbott Laboratories' fiscal year end?
Abbott Laboratories' fiscal year end is December 31.
When was the 10-K filing for Abbott Laboratories submitted?
The 10-K filing was submitted on February 21, 2025.
What is Abbott Laboratories' Central Index Key?
Abbott Laboratories' Central Index Key is 0000001800.
What is the Standard Industrial Classification for Abbott Laboratories?
The Standard Industrial Classification for Abbott Laboratories is Pharmaceutical Preparations [2834].
What is the business address of Abbott Laboratories?
The business address of Abbott Laboratories is 100 Abbott Park Road, Abbott Park, IL 60064-3500.
From the Filing
0001628280-25-007110.txt : 20250221 0001628280-25-007110.hdr.sgml : 20250221 20250221160720 ACCESSION NUMBER: 0001628280-25-007110 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 118 CONFORMED PERIOD OF REPORT: 20241231 FILED AS OF DATE: 20250221 DATE AS OF CHANGE: 20250221 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ABBOTT LABORATORIES CENTRAL INDEX KEY: 0000001800 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 360698440 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-02189 FILM NUMBER: 25651759 BUSINESS ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 BUSINESS PHONE: 2246676100 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 10-K 1 abt-20241231.htm 10-K abt-20241231 0000001800 2024 FY false P1M P2Y P8Y http://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpense http://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpense http://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpense http://fasb.org/us-gaap/2024#OtherNonoperatingIncomeExpense http://fasb.org/us-gaap/2024#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2024#ResearchAndDevelopmentExpense 0.3333 http://fasb.org/us-gaap/2024#DeferredIncomeTaxesAndOtherAssetsNoncurrent http://fasb.org/us-gaap/2024#DeferredIncomeTaxesAndOtherAssetsNoncurrent http://fasb.org/us-gaap/2024#OtherAccruedLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherAccruedLiabilitiesCurrent http://www.abbott.com/20241231#PostEmploymentObligationsDeferredIncomeTaxesAndOtherLongTermLiabilities http://www.abbott.com/20241231#PostEmploymentObligationsDeferredIncomeTaxesAndOtherLongTermLiabilities P12M http://fasb.org/us-gaap/2024#LongTermDebtNoncurrent http://fasb.org/us-gaap/2024#LongTermDebtNoncurrent iso4217:USD xbrli:shares iso4217:USD xbrli:shares abt:segment xbrli:pure abt:intangibleAsset iso4217:EUR iso4217:JPY 0000001800 2024-01-01 2024-12-31 0000001800 exch:XNYS 2024-01-01 2024-12-31 0000001800 exch:XCHI 2024-01-01 2024-12-31 0000001800 2024-06-28 0000001800 2025-01-31 0000001800 2023-01-01 2023-12-31 0000001800 2022-01-01 2022-12-31 0000001800 2024-12-31 0000001800 2023-12-31 0000001800 2022-12-31 0000001800 2021-12-31 0000001800 us-gaap:CommonStockMember 2023-12-31 0000001800 us-gaap:CommonStockMember 2022-12-31 0000001800 us-gaap:CommonStockMember 2021-12-31 0000001800 us-gaap:CommonStockMember 2024-01-01 2024-12-31 0000001800 us-gaap:CommonStockMember 2023-01-01 2023-12-31 0000001800 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0000001800 us-gaap:CommonStockMember 2024-12-31 0000001800 us-gaap:TreasuryStockCommonMember 2023-12-31 0000001800 us-gaap:TreasuryStockCommonMember 2022-12-31 0000001800 us-gaap:TreasuryStockCommonMember 2021-12-31 0000001800 us-gaap:TreasuryStockCommonMember 2024-01-01 2024-12-31 0000001800 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-12-31 0000001800 us-gaap:TreasuryStockCommonMember 2022-01-01 2022-12-31 0000001800 us-gaap:TreasuryStockCommonMember 2024-12-31 0000001800 us-gaap:RetainedEarningsMember 2023-12-31 0000001800 us-gaap:RetainedEarningsMember 2022-12-31 0000001800 us-gaap:RetainedEarningsMember 2021-12-31 0000001800 us-gaap:RetainedEarningsMember 2024-01-01 2024-12-31 0000001800 us-gaap:RetainedEarningsMember 2023-01-01 2023-12-31 0000001800 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0000001800 us-gaap:RetainedEarningsMember 2024-12-31 0000001800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0000001800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000001800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0000001800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-12-31 0000001800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-12-31 0000001800 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0000001800 us-gaap: